Pamisel, Top Search Ranking... Stock Price Up 3.56%

As of 9:30 AM on the 29th, Pamicell is trading at 23,300 KRW, up 3.56% from the previous day. This marks a 22.63% increase compared to April 29. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Over the past five days, individual investors have net sold 41,071 shares, while foreigners and institutions have net bought 82,205 shares and 72,425 shares, respectively.

On May 26, Pamicell became a market topic with the news "Remdesivir special import possible... bullish."

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.